Healthcare Purchasing News
  • Magazine
  • Continuing Education
  • Webinars
  • Whitepapers
  • Videos
  • Events
  • Hall of Fame
  • Advertise
  • Source Guide
  • Subscribe
  • Sourcing & Logistics
  • Sterile Processing
  • Surgical & Critical Care
  • Patient Satisfaction
  • Infection Prevention
  • EVS & Facility Services
  • Healthcare IT
  • Regulatory
  • Topics
    Sourcing & LogisticsSterile ProcessingSurgical & Critical CarePatient SatisfactionInfection PreventionEVS & Facility ServicesHealthcare ITRegulatory
    Resources
    HPN Source GuideContinuing EducationWebinarsWhitepapersVideosEventsHall of FameAdvertiseAd Specs
    User Tools
    SubscribeContact UsAbout UseNewsletterMagazinesPrivacy PolicyTerms & Conditions
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    1. Infection Prevention

    Fewer cardiac events seen in vaccinated people after COVID-19

    Feb. 27, 2023
    Photo 186175329 © Noipornpan | Dreamstime.com
    Dreamstime Xxl 186175329

    In a study including data from almost two million individuals, COVID-19 vaccination seemed to have a protective effect against heart attacks, strokes, and cardiovascular problems linked to infection with SARS-CoV-2.

    Research shows that even a mild case of COVID-19 can result in cardiovascular complications, often linked to abnormal blood clotting and inflammation occurring as a result of the infection. These adverse effects can occur for some time after the infection has passed. 

    For example, a study published last year showed individuals who were infected with COVID-19 had a 52% increased risk for stroke and a 72% increase in risk for heart failure in the year after infection vs uninfected controls. However, the impact of vaccination status on these cardiovascular risks has not been widely studied. This led to the current research project, led by Girish N. Nadkarni, Irene and Dr. Arthur M. Fishberg Professor of Medicine at Icahn Mount Sinai, being set up. 

    Overall, 1,934,294 patients infected with SARS-CoV-2 were included in the study. Of these, 217,843 received mRNA vaccines (Pfizer-BioNTech or Moderna) or viral vector vaccines (Johnson & Johnson). 

    The team found that even partial vaccination had a protective effect against major adverse cardiovascular events (MACE) in COVID-19 patients, with full vaccination reducing the risk of MACE by 41% and partial vaccination by 24% over more than 150 days of follow-up time after infection. 

    “We sought to clarify the impact of previous vaccination on cardiovascular events among people who develop COVID-19 and found that, particularly among those with comorbidities, such as previous MACE, type 2 diabetes, high cholesterol, liver disease, and obesity, there is an association with a lower risk of complications,” said Nadkarni in a press statement. 

    “To our surprise, even partial vaccination was associated with lower risk of adverse cardiovascular events,” said first author, Joy Jiang, an MD/PhD candidate in the lab of Dr. Nadkarni. “Given the magnitude of SARS-CoV-2 infection worldwide, we hope our findings could help improve vaccination rates, especially in individuals with coexisting conditions.” 

    Inside Precision Medicine release

    Latest in Infection Prevention

    Photo 117616099 | Antimicrobial Resistance © Designer491 | Dreamstime.com
    Infection Prevention

    IDSA announces Antimicrobial Stewardship Centers of Excellence designation recipients

    Janette Wider
    Nov. 21, 2023
    Photo 32161147 © Fasphotographic | Dreamstime.com
    Infection Prevention

    Global measles threat continues to grow as another year passes with millions of children unvaccinated

    Nov. 21, 2023
    Photo 281959520 © Zelwanka | Dreamstime.com
    Infection Prevention

    Expedited availability of additional doses of new RSV immunization for infants

    Nov. 20, 2023
    Photo 175971946 © Adonis1969 | Dreamstime.com
    Infection Prevention

    WHO releases updated guidelines on treatments for COVID-19

    Nov. 16, 2023
    Photo 124874066 © Marian Vejcik | Dreamstime.com
    Infection Prevention

    FDA approves vaccine to prevent disease caused by chikungunya virus

    Nov. 14, 2023
    Healthcare Purchasing News
    https://www.facebook.com/hpnonline
    https://www.linkedin.com/company/healthcare-purchasing-news/
    https://twitter.com/HPN_Online
    • About Us
    • Contact Us
    • Advertise
    • Do Not Sell or Share
    • Privacy Policy
    • Terms & Conditions
    © 2023 Endeavor Business Media, LLC. All rights reserved.
    Endeavor Business Media Logo